New Delhi, December 18, 2018: India Ratings and Research (Ind-Ra) believes that Cipla Limited’s (IND AAA/Stable) proposed acquisition of the…
Upon first stage closing, InvaGen Pharmaceuticals Inc., a Cipla subsidiary (“InvaGen”), to acquire shares representing a 33.3% stake in Avenue…